Notícias

Chipotle Mexican Grill stock is valued above the market on earnings while running a thinner margin, and the growth paying for that gap now comes mostly from opening restaurants.

According to a Reuters report, a senior source denied merger discussions between AstraZeneca and Bristol Myers Squibb.

Chipotle's share price has swung wildly for two years, and now management is buying back stock aggressively near current levels while Wall Street eyes a 27% upside. The real question is whether the operational recovery has enough traction to survive margin pressure, a fragile consumer, and fresh food safety concerns.

The March start date means Paramount will owe more than $1 billion in daily penalties before a judge ever rules on the deal

CRH expands its Utah footprint with Pisgah Stone Products, adding long-life limestone reserves to support aggregates growth in a high-demand market.

Chipotle Mexican Grill (NYSE:CMG) rose around 3. 5% in pre-market trading on Wednesday after Minnesota health officials said they have no ongoing concerns about the company following a recent salmonella outbreak investigation.

AstraZeneca (NASDAQ:AZN) shares climbed around 6% on Wednesday after Reuters reported that there are “no discussions” between the company and Bristol Myers Squibb (NYSE:BMY) regarding a potential merger, contradicting recent speculation that had unsettled investors. The report eased concerns surrounding a deal that, if completed, would have created a pharmaceutical group valued at close to $400 billion.

Investing.com -- Chipotle Mexican Grill (NYSE: CMG) is signaling a 3.5% pre-market rebound ahead of Wednesday’s open after Minnesota health officials confirmed they have no ongoing concerns with the chain. The official clearance offers the clearest exoneration yet following Tuesday’s 9.72% plunge — the stock’s steepest single-day drop in nine months. The recovery stems from an August 5 SEC filing in which Chipotle revealed that the Minnesota Department of Health (MDH) had completely cleared it o

A source close to the matter told Reuters there is "no deal" and there "never was a deal to be done" between the two drugmakers

Chief Executive Mike Doustdar’s comments come amid sector focus on M&A and after Novo Nordisk made two disclosures in recent days on its future pipeline that disappointed investors.

AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are the two directly affected public companies; AZN bears the most immediate price risk given it absorbed a roughly 9% single-day selloff on Monday when the merger speculation first emerged, while BMY shareholders were widely viewed as the primary beneficiaries of any combination.

Investors are waiting for a potential Anthropic IPO in the coming months, but buying Micron and Nvidia could be a smarter bet.

Revenue rose 92% and beat estimates in the first report as a public company

Amazon and Alphabet are smart backdoor ways to gain exposure to Anthropic while owning two AI giants built to win (with or without the start-up).

Joby Aviation (NYSE:JOBY) has partnered with Atoms to develop vertiport sites in the U.S. for electric vertical takeoff and landing, or eVTOL, operations. The collaboration targets key markets that are part of the White House backed eVTOL Integration Pilot Program. The agreement focuses on turning selected locations into next generation transportation hubs to support future urban air mobility services. Joby Aviation is working to bring eVTOL air taxi services to market, and this new...

Crypto is creating a parallel market where investors can value companies before they go public.

The brand, which has faced many food safety scares over the years, said its ingredient traceability system identified a batch of peppers that may have been contaminated.

Devon Energy reported second-quarter net earnings of $1.9 billion as production reached the upper end of its forecast following the completion of its merger with Coterra Energy.

Paramount Skydance (NasdaqGS:PSKY) has received formal clearance from the European Commission for its acquisition of Warner Bros. Discovery. This approval addresses a key regulatory step in Europe after reviews in multiple major jurisdictions. The decision was announced as most global regulatory approvals for the transaction have now been secured. For investors following Paramount Skydance, the company operates at the intersection of filmed entertainment, television and streaming, where...

Is Chipotle facing another food safety crisis?

Caption: Chipotle is removing jalapeños from its menu in Minnesota after potentially being linked to the Salmonella outbreak, according to reports. 🌶️ The stock dipped nearly 9% following the news on Tuesday. Explore more premium news and analysis on Chipotle in AlphaSpace:

Paramount CEO David Ellison said Tuesday that the legal battle over his proposed multibillion-dollar takeover of Warner Bros.Ellison's Paramount Skydance agreed late last month to delay its $110 billion merger with Warner Bros.

IREN acquired software firm Mirantis for $625 million in an all-stock deal, with Mirantis operating as a standalone subsidiary that continues serving its existing customers while IREN taps it for…

Shares plunged 10% after reports tied a food-safety issue to produce at multiple locations, on Aug. 4, 2026.

Gilead Sciences posts higher revenue as its market-leading HIV drug portfolio continues to drive growth.

Chipotle Mexican Grill’s stock is taking a hit after the chain pulled ingredients tied to a Salmonella outbreak.

Yahoo Finance Senior Reporter Brooke DiPalma and Market Domination host Josh Lipton take a closer look at one of Tuesday's trending stories: Chipotle (CMG) pulling its jalapeños due to salmonella concerns. Watch the video above to learn more. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help retail investors understand markets.

Another foodborne illness outbreak spooked investors.

Chipotle Mexican Grill has pulled jalapeños from several Minnesota restaurants following a state Salmonella outbreak that has infected more than 100 people.

A jalapeño recall, a decade-old reputation problem and a nationwide parasite outbreak are colliding at the worst possible moment for America’s burrito supply chain